Cutter Capital Management, LP Bridge Bio Pharma, Inc. Transaction History
Cutter Capital Management, LP
- $244 Billion
- Q4 2024
A detailed history of Cutter Capital Management, LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 560,344 shares of BBIO stock, worth $18.3 Million. This represents 6.3% of its overall portfolio holdings.
Number of Shares
560,344
Previous 396,388
41.36%
Holding current value
$18.3 Million
Previous $10.1 Billion
52.36%
% of portfolio
6.3%
Previous 2.98%
Shares
4 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$823 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$819 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$491 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$406 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$201 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.83B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...